SAN FRANCISCO — XCaliber Health announced on Tuesday that it secured $6.5 million in a seed funding round to advance product development within the healthcare sector. ManchesterStory led the investment round, which closed on Tuesday, according to the startup.
The $6.5 million in new capital will support the company as it seeks to expand across the healthcare market, ManchesterStory said. XCaliber Health did not disclose the specific valuation of the firm following the Tuesday transaction, nor did it provide a detailed budget breakdown for the funds.
The chief executive officer of XCaliber Health said on Tuesday that the funding allows the company to enhance its offerings and improve patient outcomes through its technology. The firm confirmed it will work with ManchesterStory, Benhamou Global Ventures, and Arka Venture Labs to achieve its goals, but gave no specific release timeline for new product features.
Benhamou Global Ventures and Arka Venture Labs joined the round to support the growth of XCaliber Health, bringing the total number of participating investors to three firms. The healthcare technology sector has seen increased activity during the 2024 calendar year, providing XCaliber Health with resources for future development.
XCaliber Health plans to explore new growth avenues following the receipt of the $6.5 million, evaluating potential technology advancements throughout the remainder of 2024. Management did not specify when the next round of funding might occur or if the company plans to hire additional staff from its headquarters.
